UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Advances in Pharmacokinetics and Pharmacodynamics

Macheras, Panos

1st ed. 2023., 2023

Volltextzugriff (PDF)

Revising Pharmacokinetics of Oral Drug Absorption: I Models Based on Biopharmaceutical/Physiological and Finite Absorption Time Concepts

Pharmaceutical research, 2020-10, Vol.37 (10), p.187, Article 187

2020

Volltextzugriff (PDF)

A century of dissolution research: From Noyes and Whitney to the Biopharmaceutics Classification System

International journal of pharmaceutics, 2006-09, Vol.321 (1), p.1-11

2006

Volltextzugriff (PDF)

A fractal kinetics SI model can explain the dynamics of COVID-19 epidemics

PloS one, 2020-08, Vol.15 (8), p.e0237304-e0237304

2020

Volltextzugriff (PDF)

Re-examining digoxin bioavailability after half a century: Time for changes in the bioavailability concepts

Pharmaceutical research, 2021-10, Vol.38 (10), p.1635-1638

2021

Volltextzugriff (PDF)

Re-writing Oral Pharmacokinetics Using Physiologically Based Finite Time Pharmacokinetic (PBFTPK) Models

Pharmaceutical research, 2022-04, Vol.39 (4), p.691-701

2022

Volltextzugriff (PDF)

Correction to: Re-examining digoxin bioavailability after half a century: Time for changes in the bioavailability concepts

Pharmaceutical research, 2021-12, Vol.38 (12), p.2185-2185

2021

Volltextzugriff (PDF)

Revising Pharmacokinetics of Oral Drug Absorption: II Bioavailability-Bioequivalence Considerations

Pharmaceutical research, 2021-08, Vol.38 (8), p.1345-1356

2021

Volltextzugriff (PDF)

Correction to: Revising Pharmacokinetics of Oral Drug Absorption: II Bioavailability-Bioequivalence Considerations

Pharmaceutical research, 2021-09, Vol.38 (9), p.1633-1633

2021

Volltextzugriff (PDF)

On the use of the Weibull function for the discernment of drug release mechanisms

International journal of pharmaceutics, 2006-02, Vol.309 (1), p.44-50

2006

Volltextzugriff (PDF)

On the ubiquitous presence of fractals and fractal concepts in pharmaceutical sciences: A review

International journal of pharmaceutics, 2013-11, Vol.456 (2), p.340-352

2013

Volltextzugriff (PDF)

On an Unphysical Hypothesis of Bateman Equation and its Implications for Pharmacokinetics

Pharmaceutical research, 2019-07, Vol.36 (7), p.94-3, Article 94

Macheras, Panos

2019

Volltextzugriff (PDF)

Interpreting airborne pandemics spreading using fractal kinetics' principles [version 1; peer review: 2 approved, 1 approved with reservations]

F1000 research, 2021, Vol.10, p.609-609

2021

Volltextzugriff (PDF)

Revising Oral Pharmacokinetics, Bioavailability and Bioequivalence Based on the Finite Absorption Time Concept

1, 2023

Volltextzugriff (PDF)

Fractal kinetics in drug release from finite fractal matrices

The Journal of chemical physics, 2003-09, Vol.119 (12), p.6373-6377

2003

Volltextzugriff (PDF)

On the dilemma of fractal or fractional kinetics in drug release studies: A comparison between Weibull and Mittag-Leffler functions

International journal of pharmaceutics, 2018-05, Vol.543 (1-2), p.269-273

2018

Volltextzugriff (PDF)

Quantitative biopharmaceutics classification system: The central role of dose/solubility ratio

Pharmaceutical research, 2003-12, Vol.20 (12), p.1917-1925

2003

Volltextzugriff (PDF)

Drugs are Absorbed in Finite Time: A New Era in Biopharmaceutics and Pharmacokinetics

Acta Pharmaceutica Hungarica, 2021-11, Vol.91 (3-4), p.148-149

Macheras, Panos

2021

Volltextzugriff (PDF)

The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines

International journal of pharmaceutics, 2019-07, Vol.566, p.264-281

2019

Volltextzugriff (PDF)

Correction to: Revising Pharmacokinetics of Oral Drug Absorption: I Models Based on Biopharmaceutical/Physiological and Finite Absorption Time Concepts

Pharmaceutical research, 2020-10, Vol.37 (10), p.206-206, Article 206

2020

Volltextzugriff (PDF)

Modeling in Biopharmaceutics, Pharmacokinetics and Pharmacodynamics: Homogeneous and Heterogeneous Approaches

Second edition., 2016

Volltextzugriff (PDF)

Coupling Drug Dissolution with BCS

Pharmaceutical research, 2024-03, Vol.41 (3), p.481-491

2024

Volltextzugriff (PDF)

Examining the role of metabolites in bioequivalence assessment

Journal of pharmacy & pharmaceutical sciences, 2010-01, Vol.13 (2), p.198

2010

Volltextzugriff (PDF)

Biopharmaceutic classification of drugs revisited

European journal of pharmaceutical sciences, 2016-12, Vol.95, p.82-87

2016

Volltextzugriff (PDF)

Milk as a medium for pediatric formulations: Experimental findings and regulatory aspects

International journal of pharmaceutics, 2015-08, Vol.492 (1-2), p.344-345

2015

Volltextzugriff (PDF)

1 – 25 von 206

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(198)

Publikationsform

Sprache

Englisch
(206)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Advances in Pharmacokinetics and Pharmacodynamics

Revising Pharmacokinetics of Oral Drug Absorption: I Models Based on Biopharmaceutical/Physiological and Finite Absorption Time Concepts

A century of dissolution research: From Noyes and Whitney to the Biopharmaceutics Classification System

A fractal kinetics SI model can explain the dynamics of COVID-19 epidemics

Re-examining digoxin bioavailability after half a century: Time for changes in the bioavailability concepts

Re-writing Oral Pharmacokinetics Using Physiologically Based Finite Time Pharmacokinetic (PBFTPK) Models

Correction to: Re-examining digoxin bioavailability after half a century: Time for changes in the bioavailability concepts

Revising Pharmacokinetics of Oral Drug Absorption: II Bioavailability-Bioequivalence Considerations

Correction to: Revising Pharmacokinetics of Oral Drug Absorption: II Bioavailability-Bioequivalence Considerations

On the use of the Weibull function for the discernment of drug release mechanisms

On the ubiquitous presence of fractals and fractal concepts in pharmaceutical sciences: A review

On an Unphysical Hypothesis of Bateman Equation and its Implications for Pharmacokinetics

Interpreting airborne pandemics spreading using fractal kinetics' principles [version 1; peer review: 2 approved, 1 approved with reservations]

Revising Oral Pharmacokinetics, Bioavailability and Bioequivalence Based on the Finite Absorption Time Concept

Fractal kinetics in drug release from finite fractal matrices

On the dilemma of fractal or fractional kinetics in drug release studies: A comparison between Weibull and Mittag-Leffler functions

Quantitative biopharmaceutics classification system: The central role of dose/solubility ratio

Drugs are Absorbed in Finite Time: A New Era in Biopharmaceutics and Pharmacokinetics

The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines

Correction to: Revising Pharmacokinetics of Oral Drug Absorption: I Models Based on Biopharmaceutical/Physiological and Finite Absorption Time Concepts

Modeling in Biopharmaceutics, Pharmacokinetics and Pharmacodynamics: Homogeneous and Heterogeneous Approaches

Coupling Drug Dissolution with BCS

Examining the role of metabolites in bioequivalence assessment

Biopharmaceutic classification of drugs revisited

Milk as a medium for pediatric formulations: Experimental findings and regulatory aspects

Suchergebnisse filtern